Heart monitor by post could cut stroke risk, major study hopes

NCT ID NCT07343895

Recruiting now Knowledge-focused Sponsor: University Hospital of North Norway Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether sending a portable ECG monitor to people with elevated NT-proBNP (a heart stress marker) can catch hidden atrial fibrillation and reduce strokes. 4,000 adults aged 40+ without known AF will be randomly assigned to either 7 days of home monitoring or no monitoring. Researchers will track strokes and heart-related deaths over 6 years using national registries.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: long-term ECG monitoring device (ECG247)
What this could lead to: If successful, this could show that screening high-risk people with a home ECG device helps prevent strokes and deaths from heart problems.
What could go wrong: This is an observational screening study, not a treatment trial. It may not prove that monitoring directly causes fewer strokes, and results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation Cognitive Dysfunction heart failure stroke disorder ischemic stroke prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATRIAL FIBRILLATION (AF) COGNITIVE FUNCTION AND WELL-BEING HEART FAILURE NT-PRO-BNP STROKE

Heart monitor by post could cut stroke risk, major study hopes

Summary

What this could mean

Get notified about this study

Conditions

As listed by the trial registrant

Contacts and locations

Locations

More trials for these conditions